Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
about
H pylori antibiotic resistance: prevalence, importance, and advances in testingMeta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pyloriMacrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype.Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration.Macrolide resistance conferred by base substitutions in 23S rRNA.Helicobacter pylori infection--current treatment practice.Alternative and rescue treatment regimens for Helicobacter pylori eradication.Efficacy of levofloxacin and rifaximin based quadruple therapy in Helicobacter pylori associated gastroduodenal disease: a double-blind, randomized controlled trial.In Vitro Activity of 2-methoxy-1,4-naphthoquinone and Stigmasta-7,22-diene-3β-ol from Impatiens balsamina L. against Multiple Antibiotic-Resistant Helicobacter pyloriAntimicrobial susceptibility testing of 230 Helicobacter pylori strains: importance of medium, inoculum, and incubation time.Prevalence of primary Helicobacter pylori resistance to metronidazole and clarithromycin in Singapore.Antibiotic resistance of Helicobacter pylori from patients in Ile-Ife, South-west, Nigeria.Detection of A2142C, A2142G, and A2143G Mutations in 23s rRNA Gene Conferring Resistance to Clarithromycin among Helicobacter pylori Isolates in Kerman, Iran.Helicobacter pylori: perspectives and time trends.Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin.Explaining the bias in the 23S rRNA gene mutations associated with clarithromycin resistance in clinical isolates of Helicobacter pylori.The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.A pilot study to determine the effectiveness of garlic oil capsules in the treatment of dyspeptic patients with Helicobacter pylori.Clarithromycin resistance in Helicobacter pylori and its clinical relevance.Comparative efficacy of new investigational agents against Helicobacter pylori.Antibiotic susceptibility of Helicobacter pylori in the Chinese population.Triple therapy with clarithromycin, amoxicillin and omeprazole for Helicobacter pylori eradication in children and adolescents.A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.Metronidazole- and clarithromycin-resistant Helicobacter pylori in dyspeptic patients in western Sydney as determined by testing multiple isolates from different gastric sites.Efficacy of a multistep strategy for Helicobacter pylori eradication.Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.Dynamics of Helicobacter pylori infection in early childhood in a high-risk group living in Germany: loss of infection higher than acquisition
P2860
Q24685864-2E7B4F4A-BD9B-4AD1-977B-673FF08E4C8FQ33627553-45AA46B8-1337-42F4-B936-413C5B075FEFQ33695797-16D3E348-D1A7-41F0-A2D4-1B7AB23F46F5Q33883691-D159B9DB-7BAF-4FA7-A297-27AC664E6F35Q33889788-271B7811-6449-4B62-BA1D-7E937EC27AD5Q34106180-EB715EE0-0967-4DD1-A70B-9B3B3DCBAADFQ34240824-D1BDD481-E9C4-455D-83DF-483232E2D72FQ34789141-D7BF79ED-599F-4E37-A733-686440829F0FQ35009862-89086EA3-B053-427D-B24C-4F005DD2A159Q35108009-E38D66C3-C7BA-4E25-80B2-D03292B5678FQ35139348-5B28F9BE-1B38-46D0-BCA5-AA937A463560Q36492096-651E29DF-FDA9-47AA-A011-7CAC8C5E016FQ36500730-AFADBF0C-4E12-408B-8C06-F1B1BEF9DE04Q36567075-751ADB2F-A141-4E75-B744-8CA968F1E026Q38227090-81C929BF-31E5-4F52-8D52-E4DE48EF9ED9Q39469846-CBAA01A8-3048-44CB-BB1C-512B3F836BC7Q39559265-B96745D8-7C66-45C3-8E19-BE59C2B64002Q40626311-13CE546C-F379-4ACE-904A-7403ED70CC14Q40679020-6CC7A80F-21F5-43DC-B969-97DB453BCAFDQ43119348-7E834BD6-6C10-45AA-94E6-2578280521A6Q43563785-306BD747-E638-4BD9-9869-7F4BECC69CECQ43762359-EB2DCF4A-AE11-4F38-AA18-1CC4E5F7205BQ43935943-E44C08A3-ECBF-4C57-A844-5D711D7495DBQ44281134-8BCD48B8-393E-4759-A4FB-254086F2FA7FQ45280269-54B0A2BB-E937-4CCE-8BCC-4FBD760F5D1EQ52083004-0813B6D5-59FA-4B30-B9E7-5D0CC456AA70Q54098618-33CF4679-2987-4A5A-9AC1-A81BD95DA0A7Q57192667-AFDA8CA1-A47B-42E6-8140-1389382907F3
P2860
Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Clarithromycin resistance in H ...... tients and stability in vitro.
@en
Clarithromycin resistance in H ...... tients and stability in vitro.
@nl
type
label
Clarithromycin resistance in H ...... tients and stability in vitro.
@en
Clarithromycin resistance in H ...... tients and stability in vitro.
@nl
prefLabel
Clarithromycin resistance in H ...... tients and stability in vitro.
@en
Clarithromycin resistance in H ...... tients and stability in vitro.
@nl
P2093
P356
P1476
Clarithromycin resistance in H ...... tients and stability in vitro.
@en
P2093
P304
P356
10.1093/JAC/37.3.473
P407
P577
1996-03-01T00:00:00Z